Read + Share
Amedeo Smart
Independent Medical Education
Hegde NC, Kumar A, Kaundal S, Saha L, et al. Generic ibrutinib a potential cost-effective strategy for the first-line treatment of chronic lymphocytic leukaemia. Ann Hematol 2023;102:3125-3132.PMID: 37439892
Email
LinkedIn
Privacy Policy